Chris B, Author at J+D Forecasting

J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market

12th August 2020

J+D’s approach and the model has given the team greater confidence in the outputs and subsequent decisions they will have to make in taking the product forward.

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER!

27th July 2020

J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the release of several pharmaceutical forecasting software upgrades.

J+D Forecasting Changed the Forecasting Approach of a Global Bio Tech Forever

23rd July 2020

One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.

Improve efficiencies in your long-range/strategic planning

21st July 2020

Here we offer insight into how you can improve efficiencies in your long range strategic planning by moving to cloud-based software solutions.

Best practice tips for visualizing your pharma forecast

20th July 2020

Here we offer insight into the best practises for visualising your forecast, from thinking about your audience to interacting with data.

How to choose the most appropriate trending approach for a sales forecast

18th June 2020

When you are creating a sales-based forecast there can be a wide range of sophisticated forecasting methodologies available to you.

Forecasting by biomarker, not tumour type

18th June 2020

If you are forecasting for an asset across multiple tumour types, forecasting using biomarkers may be a favourable approach for you.

The Unique Challenges and Opportunities of Forecasting for Orphan Diseases

15th June 2020

An article written by David James, IPI - International Pharmaceutical Industry

Running a risk analysis on consolidated revenues

15th June 2020

This post will look at Epidemiology Forecasting, and running a risk analysis on consolidated revenues.

Accounting for chronic patients in your forecast

15th June 2020

This post will look at Oncology Forecasting, and accounting for chronic patients in your forecast.

PHARMA FORECASTING SOFTWARE FOR GREATER EFFICIENCY AND ENJOYMENT

19th May 2020

J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced an upgrade and an extension to the FC+ suite.

J+D Forecasting provides Online Team Pharma Forecasting Training

18th May 2020

Following the success of J+D's face to face training, the content has been redesigned to make it suitable for an online audience. The training can be tailored to individual teams/departments within specific organisations or completed independently.